Is there any information on how Neuren arrived at their figures? If the premise is that fewer patients are diagnosed due to the unavailability of treatment, which keeps the number of known cases low, then where does Neuren obtain the data to justify their estimates?
If the known population is so different to Neuren estimates then how are these prevalence rates derived?
Is there any information on how Neuren arrived at their figures?...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.04 |
Change
-0.500(3.99%) |
Mkt cap ! $1.507B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $1.858M | 154.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 140 | $12.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.06 | 536 | 6 |
View Market Depth
| Last trade - 11.03am 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |